A detailed history of South Dakota Investment Council transactions in Dexcom Inc stock. As of the latest transaction made, South Dakota Investment Council holds 21,883 shares of DXCM stock, worth $1.67 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
21,883
Previous 18,056 21.2%
Holding current value
$1.67 Million
Previous $2.05 Million 28.33%
% of portfolio
0.03%
Previous 0.04%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$64.0 - $116.06 $244,928 - $444,161
3,827 Added 21.2%
21,883 $1.47 Million
Q2 2024

Aug 08, 2024

SELL
$110.31 - $140.45 $2,647 - $3,370
-24 Reduced 0.13%
18,056 $2.05 Million
Q1 2024

May 02, 2024

SELL
$114.22 - $140.1 $308,394 - $378,270
-2,700 Reduced 12.99%
18,080 $2.51 Million
Q4 2023

Feb 01, 2024

SELL
$75.49 - $124.16 $83,039 - $136,576
-1,100 Reduced 5.03%
20,780 $2.58 Million
Q3 2023

Nov 07, 2023

SELL
$86.06 - $137.93 $310,074 - $496,961
-3,603 Reduced 14.14%
21,880 $2.04 Million
Q2 2023

Aug 10, 2023

SELL
$112.47 - $130.98 $44,988 - $52,391
-400 Reduced 1.55%
25,483 $3.28 Million
Q1 2023

May 10, 2023

SELL
$104.0 - $122.92 $540,800 - $639,184
-5,200 Reduced 16.73%
25,883 $3.01 Million
Q3 2022

Nov 09, 2022

BUY
$76.35 - $94.18 $64,363 - $79,393
843 Added 2.79%
31,083 $2.5 Million
Q2 2022

Aug 11, 2022

BUY
$67.99 - $132.89 $1.81 Million - $3.54 Million
26,630 Added 737.67%
30,240 $2.25 Million
Q1 2022

May 10, 2022

SELL
$94.08 - $130.2 $125,126 - $173,165
-1,330 Reduced 26.92%
3,610 $1.85 Million
Q4 2021

Feb 08, 2022

SELL
$129.87 - $162.82 $103,896 - $130,256
-800 Reduced 13.94%
4,940 $2.65 Million
Q2 2021

Aug 11, 2021

BUY
$80.99 - $107.93 $464,882 - $619,518
5,740 New
5,740 $2.45 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.5B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track South Dakota Investment Council Portfolio

Follow South Dakota Investment Council and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of South Dakota Investment Council, based on Form 13F filings with the SEC.

News

Stay updated on South Dakota Investment Council with notifications on news.